A teenager gets a dose of the Pfizer/BioNTech Covid-19 vaccine at a drive-through clinic in California. Moderna will seek approval for its Covid-19 vaccine to be used in teens in June. — Bloomberg
American biotech firm Moderna said on May 26 (2021) that clinical trials have shown that its Covid-19 vaccine is “highly effective” in adolescents aged 12 to 17 years old.
The company will seek healthcare regulators’ approval next month (June 2021).
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
